This CE is published through an unrestricted educational grant from Bristol-Myers Squibb: New Therapies for Malignant Gliomas: Focus on Temozolomide and Irinotecan
| Autor: | Chandramouli, Jane, Tyler, Linda S, Hoffman, Jennifer M. |
|---|---|
| Zdroj: | Hospital Pharmacy; March 2000, Vol. 35 Issue: 3 p257-272, 16p |
| Abstrakt: | Credit This lesson is good for 0.2 CE units, with a passing grade of 70%.Goal The goal of this program is to inform the participant about common types of malignant gliomas and to discuss new treatment modalities.Objectives At the completion of this program the participant will be able to: |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|